Artocarpin Induces Apoptosis in Human Cutaneous Squamous Cell Carcinoma HSC-1 Cells and Its Cytotoxic Activity Is

Stephen Chu-Sung Hu1, Chi-Ling Lin2, Hui-Min Cheng3

  • 1Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan ; Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Insights

Artocarpin, a natural compound, effectively reduced human squamous cell carcinoma (SCC) viability and induced apoptosis. Its efficacy was higher in low protein concentrations, suggesting potential for SCC treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Artocarpin is a prenylated flavonoid with known biological activities.
  • The effects of artocarpin on human cutaneous squamous cell carcinoma (SCC) remain uninvestigated.

Purpose of the Study:

  • To determine the cytotoxic effects of artocarpin on human cutaneous SCC cells.
  • To investigate the dependence of artocarpin's pharmacological activity on protein-nutrient concentration.

Main Methods:

  • Treatment of HSC-1 cells (human cutaneous SCC cell line) with artocarpin.
  • Assessment of cell viability, apoptosis (caspase 3/7 activity), and protein signaling pathways (MAPK, Akt/mTOR).
  • High-performance liquid chromatography (HPLC) analysis to determine artocarpin uptake under varying fetal bovine serum (FBS) concentrations.

Main Results:

  • Artocarpin decreased HSC-1 cell viability and induced apoptosis.
  • Effects were more pronounced at low FBS concentrations.
  • Artocarpin modulated MAPK and Akt/mTOR signaling pathways.
  • High FBS concentrations inhibited artocarpin uptake into cells.

Conclusions:

  • Artocarpin induces apoptosis in human cutaneous SCC cells via MAPK and Akt/mTOR pathway modulation.
  • Protein binding in FBS may reduce artocarpin's cellular uptake and cytotoxic activity.
  • Artocarpin shows potential as a future therapeutic agent for cutaneous SCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
17.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K